1. Home
  2. BIO vs AS Comparison

BIO vs AS Comparison

Compare BIO & AS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • AS
  • Stock Information
  • Founded
  • BIO 1952
  • AS 1950
  • Country
  • BIO United States
  • AS Finland
  • Employees
  • BIO N/A
  • AS N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • AS
  • Sector
  • BIO Industrials
  • AS
  • Exchange
  • BIO Nasdaq
  • AS NYSE
  • Market Cap
  • BIO 9.1B
  • AS 9.5B
  • IPO Year
  • BIO N/A
  • AS 2024
  • Fundamental
  • Price
  • BIO $323.65
  • AS $23.62
  • Analyst Decision
  • BIO Strong Buy
  • AS Buy
  • Analyst Count
  • BIO 4
  • AS 14
  • Target Price
  • BIO $411.00
  • AS $21.43
  • AVG Volume (30 Days)
  • BIO 211.4K
  • AS 2.2M
  • Earning Date
  • BIO 10-30-2024
  • AS 11-19-2024
  • Dividend Yield
  • BIO N/A
  • AS N/A
  • EPS Growth
  • BIO N/A
  • AS N/A
  • EPS
  • BIO N/A
  • AS N/A
  • Revenue
  • BIO $2,580,209,000.00
  • AS $4,843,300,000.00
  • Revenue This Year
  • BIO N/A
  • AS $19.93
  • Revenue Next Year
  • BIO $3.61
  • AS $13.21
  • P/E Ratio
  • BIO N/A
  • AS N/A
  • Revenue Growth
  • BIO N/A
  • AS 13.90
  • 52 Week Low
  • BIO $262.12
  • AS $10.11
  • 52 Week High
  • BIO $387.99
  • AS $21.68
  • Technical
  • Relative Strength Index (RSI)
  • BIO 39.02
  • AS 70.30
  • Support Level
  • BIO $306.42
  • AS $18.56
  • Resistance Level
  • BIO $387.99
  • AS $20.68
  • Average True Range (ATR)
  • BIO 12.82
  • AS 1.00
  • MACD
  • BIO -5.89
  • AS 0.16
  • Stochastic Oscillator
  • BIO 21.17
  • AS 97.42

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About AS AMER SPORTS INC

Amer Sports manages a diverse portfolio of 10 outdoor and action sports brands that collectively generated revenue of $4.4 billion in 2023. Although primarily owned by the Chinese conglomerate Anta Sports, Amer operates with a degree of autonomy. In its rapidly expanding China business, the company is subject to closer oversight, but it manages its operations outside of China with relative independence. In 2023, the firm generates 40% of its revenue from the Americas, 33% from Europe, the Middle East, and Africa, 19% from China, and 7% from Asia-Pacific, excluding China.

Share on Social Networks: